National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

triptorelin
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:6-D-Tryptophan-LH-RH
6-D-Tryptophanluteinizing Hormone-releasing Factor
Detryptoreline
D-TRP-6-LHRH
Foreign brand name:Decapeptyl
Abbreviation:TRIP
Code names:AY-25650
CL-118,532



Previous:trimethoprim-sulfamethoxazole, trimethylcolchicinic acid, trimetrexate glucuronate, Trimox, Triostat
Next:triptorelin pamoate, Trisenox, trivalent influenza vaccine, trofosfamide, troglitazone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov